Tissue biomarkersto transform oncology

Groups of all sizes - from biotech startups to global pharmaceutical companies - use GTL's platform and AI biomarkers support their pathology.

Built at one of the world's leading research organizations ↘︎

Oxford University Logo
Oxford Science Enterprises Logo
Big Data Institute Logo

Get more information from your histology slides. Our biomarkers scrutinise millions of cells and reams of fibrosis to get the complete picture.


Measurable metrics

So you can make meaningful comparisons between patients, cohorts, and treatments.

We quantified the shape, size, and texture of megakaryocytes, cells found in the bone marrow, which hold critical morphological clues to subtypes of rare blood cancer.
illustration of a library of megakaryocytes arranged by features


A better workflow

Instant probabilistic analysis from the standard diagnostic slides you already use. Easily integrates into existing workflows.

See how probabilistic calls for gene expression profiling can be made directly from the standard H&E sections in colorectal cancer.


Cohort context

See how your samples compare to a well-curated and highly annotated cohort.

Samples viewed in disease space allow for a nuanced interpretation of certainty. Intuit how cancer patients can sit between morphological subtypes in disease space.
Illustration of cohort indexing: showing a few patient samples in the context of disease space.

A better way to analyse tissue

report example

Boost your histology.
Start using tissue biomarkers today.

We're applying tissue biomarkers to trials, research and clinical audits today. Let's talk about custom application for your study.